CME Group's lower projected growth might not justify its hig...

CME Group's lower projected growth might not justify its high P/E ratio. Investors more bullish than analysts could face disappointment if the P/E falls. Current high P/E ratio and slower forecasted earnings growth suggest a potential share price decline, posing a risk to shareholders.